Literature DB >> 19892574

Frequency of positive XmnIGgamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation.

Maryam Neishabury1, Azita Azarkeivan, Hossein Najmabadi.   

Abstract

From 362 thalassemia cases referred to adult thalassemia clinic of the Iranian blood transfusion organization (IBTO) for genotyping, 103 cases (28.5%) had a common primary disease factor, IVSII-1 mutation in homozygous state. 61 (59.2%) of these individuals represented thalassemia major and 42 (40.8%) thalassemia intermedia clinical phenotype. To re-evaluate our current diagnostic criteria, XmnI(G)gamma polymorphism and coexistence of alpha thalassemia mutations, frequently recalled as important factors modifying the clinical phenotype of homozygous beta zero thalassemia cases in our country, were examined in both groups. No statistically significant difference in the frequency of positive XmnI(G)gamma polymorphism was observed between thalassemia intermedia and thalassemia major patients. Double gene deletion --(Med) was observed in only one thalassemia major case, while -a(3.7) in heterozygous state (-a(3.7)/aa) was identified in 6 (9.8%) of thalassemia major and 8 (19%) of thalassemia intermedia patients. -a(4.2) was observed in only one thalassemia major case. No statistically significant difference in the frequency of coinheritance of alpha thalassemia was observed between the two groups. These results imply that other interacting mechanisms which modify the phenotype of thalassemia patients is still in the dark in our current diagnostic criteria of thalassemia. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892574     DOI: 10.1016/j.bcmd.2009.10.007

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

1.  Combination of two rare mutations causes β-thalassaemia in a Bangladeshi patient.

Authors:  Mahdi Muhammad Moosa; Mustak Ibn Ayub; Ama Emran Bashar; Golam Sarwardi; Waqar Khan; Haseena Khan; Sabina Yeasmin
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

2.  Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.

Authors:  Majid Motovali-Bashi; Tayyebeh Ghasemi
Journal:  Iran Biomed J       Date:  2015-05-30

3.  Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Authors:  Ebrahim Miri-Moghaddam; Sara Bahrami; Majid Naderi; Ali Bazi; Morteza Karimipoor
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

4.  Thalassemia Major and Intermedia Patients in East Java do not Show Fetal Hemoglobin Level Difference in Relation to XMNI Polymorphism.

Authors:  Retno Dwi Wulandari; Diana Lyrawati; Fatchiyah Fatchiyah; Loeki Enggar Fitri
Journal:  Med Arch       Date:  2020-04

5.  Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.

Authors:  Azza A G Tantawy; Nevine G Andrawes; Amany Ismaeil; Solaf A Kamel; Wessam Emam
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

6.  The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation.

Authors:  Mozhgan Hashemieh; Zahra Al Sadat Saadatmandi; Azita Azarkeivan; Hossein Najmabadi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2022-01-01

7.  What influences Hb fetal production in adulthood?

Authors:  Gisele Cristine de Souza Carrocini; Paula Juliana Antoniazzo Zamaro; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.